Author

V. C. Sandulache

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Assay:multiome· 1 Approach:statistical model· 1

Frequent Co-Authors

A. A. Osman· 1 shared A. Dhawan· 1 shared A. Hefner· 1 shared A. Mazul· 1 shared B. Beadle· 1 shared B. M. Wahle· 1 shared C. R. Pickering· 1 shared D. Adkins· 1 shared

Activity by Year

2021-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. A. Osman

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

FAK drives resistance to therapy in HPV-negative head and neck cancer in a p53-dependent manner.

P. M. Pifer, L. Yang, M. Kumar, T. Xie, M. Frederick, A. Hefner, B. Beadle, D. Molkentine, J. Molkentine, A. Dhawan, M. Abdelhakiem, A. A. Osman, J. N. Myers, C. R. Pickering, V. C. Sandulache, , H. D. Skinner

This study identifies FAK as a driver of therapy resistance in HPV-negative HNSCC, showing its role is dependent on mutant TP53.

bioRxiv · Jun 3, 2022Cancer Biology

Comparative Multiomic Analysis Reveals Low T Cell Infiltration as the Primary Feature of Tobacco Use in HPV(+) Oropharyngeal Cancer

B. M. Wahle, P. Zolkind, R. Ramirez, Z. L. Skidmore, A. Mazul, D. N. Hayes, V. C. Sandulache, W. L. Thorstad, D. Adkins, O. L. Griffith, M. Griffith, J. P. Zevallos

This study identifies low T cell infiltration as a key feature of tobacco use in HPV-positive oropharyngeal cancer, linked to worse outcomes.

bioRxiv · Mar 23, 2021 · PreprintCancer Biology